Css LLC Travere Therapeutics, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $154,956 - $222,074	-7,400 Reduced 59.68%	5,000 $121,000
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $3,894 - $7,509	300 Added 2.48%	12,400 $301,000
Q2 2021 Aug 16, 2021	BUY	$14.11 - $26.4 $42,330 - $79,200	3,000 Added 32.97%	12,100 $177,000
Q1 2021 May 17, 2021	BUY	$23.37 - $31.77 $212,667 - $289,107	9,100 New	9,100 $227,000

184

89.5M

66.9K

265K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $560M
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.